Cargando…

Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube(®): a randomized clinical trial

PURPOSE: Allergic rhinitis (AR) affects ~20% of the population worldwide. The objectives of this study were to evaluate the safety and efficacy of iodixanol nasal solution (Nasapaque) for AR treatment, using the Allergen BioCube(®) (ABC(®)), an environmental exposure unit. Iodixanol is a commonly us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Paul J, Abelson, Mark B, Stein, Linda, Viirre, Erik, Villafranca, J Ernest, Lasser, Elliott C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400136/ https://www.ncbi.nlm.nih.gov/pubmed/30881050 http://dx.doi.org/10.2147/JAA.S150251

Ejemplares similares

Technical and clinical validation of the Allergen BioCube(®) for timothy grass
por: Angjeli, Endri, et al.
Publicado: (2017)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020)

233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
por: Nurmatov, Ulugbek, et al.
Publicado: (2017)

Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis
por: Wang, Yuan, et al.
Publicado: (2023)

Meta-Analysis of the Efficacy of Ectoine Nasal Spray in Patients with Allergic Rhinoconjunctivitis
por: Eichel, Andrea, et al.
Publicado: (2014)

Nasal-Ocular Reflexes and Their Role in the Management of Allergic Rhinoconjunctivitis With Intranasal Steroids
por: Baroody, Fuad M, et al.
Publicado: (2011)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy
por: Langenbruch, Anna, et al.
Publicado: (2022)

Allergic Rhinoconjunctivitis: the Role of Histamine
por: Andersson, M., et al.
Publicado: (1994)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in mediterranean region between 2011 and 2012
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis
por: Salapatek, Anne M., et al.
Publicado: (2021)

Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review
por: Iordache, Andreea, et al.
Publicado: (2022)

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015)

Comparison of Allergic Adverse Effects and Contrast Enhancement Between Iodixanol and Iopromide
por: Gharekhanloo, Farideh, et al.
Publicado: (2012)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

Allergic rhinoconjunctivitis: pathophysiological mechanism and new therapeutic approach
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Complementary treatment of allergic rhinoconjunctivitis: the role of the nutraceutical Lertal®
por: Marseglia, Gianluigi, et al.
Publicado: (2020)

Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis
por: Ferreli, Fabio, et al.
Publicado: (2020)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine
por: Wijk, R. Gerth van
Publicado: (1995)

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options
por: Ihler, Friedrich, et al.
Publicado: (2015)

Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis
por: Meng, Yifan, et al.
Publicado: (2021)

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
por: Sager, Angelika, et al.
Publicado: (2012)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

Utility elicitation in adults and children for allergic rhinoconjunctivitis and associated health states
por: Retzler, Jenny, et al.
Publicado: (2018)

Occupational allergic rhinoconjunctivitis to Tachypleus amoebocyte lysate: a case report
por: Xu, Ying-Yang, et al.
Publicado: (2020)

Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
por: Tang, Rui, et al.
Publicado: (2022)

Preparation of Preformed Iodixanol Gradients
por: Graham, John
Publicado: (2002)

Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis
por: Pantin, Charles T, et al.
Publicado: (2019)

Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis
por: Böhm, M., et al.
Publicado: (2011)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5gfhk7g439qakbd5efrqhtc9a1